Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Tamibarotene: Phase II started

IVPH began the open-label, international, pivotal Phase II STAR-1 trial of 6 mg/m 2

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE